Vitamin D Supplementation: Does It Have a Preventative or Therapeutic Role in Cancer?

References

• Mondul AM, Weinstein SJ, Layne TM, Albanes D. Vitamin D and cancer risk and mortality: state of the science, gaps, and challenges. Epidemiol Rev. 2017;39(1):28–48.
   PubMed Web of Science ®Google Scholar
• Holick MF. Sunlight and vitamin D: both good for cardiovascular health. J Gen Intern Med. 2002;17(9):733–5.
   PubMed Web of Science ®Google Scholar
• Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014;348:g2035.
   PubMed Web of Science ®Google Scholar
• Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14(5):342–57.
   PubMed Web of Science ®Google Scholar
• Heath AK, Kim IY, Hodge AM, English DR, Muller DC. Vitamin D status and mortality: a systematic review of observational studies. Int J Environ Res Public Health. 2019;16:383–406.
   PubMed Web of Science ®Google Scholar
• Grant WB. A review of the evidence supporting the vitamin D-cancer prevention hypothesis in 2017. Anticancer Res. 2018;38(2):1121–36.
   PubMed Web of Science ®Google Scholar
• Yin L, Ordóñez-Mena JM, Chen T, Schöttker B, Arndt V, Brenner H. Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis. Prev Med. 2013;57(6):753–64.
   PubMed Web of Science ®Google Scholar
• McCullough ML, Zoltick ES, Weinstein SJ, Fedirko V, Wang M, Cook NR, Eliassen AH, Zeleniuch-Jacquotte A, Agnoli C, Albanes D, et al. Circulating vitamin D and colorectal cancer risk: an international pooling project of 17 cohorts. J Natl Cancer Inst. 2019;111(2):158–69.
   PubMedGoogle Scholar
• Bolland MJ, Chiu WW, Davidson JS, Grey A, Bacon C, Gamble GD, Reid IR. The effects of seasonal variation of 25-hydroxyvitamin D on diagnosis of vitamin D insufficiency. N Z Med J. 2008; 121(1286):63–74.
   PubMedGoogle Scholar
• Pilz S, März W, Cashman KD, Kiely ME, Whiting SJ, Holick MF, Grant WB, Pludowski P, Hiligsmann M, Trummer C, et al. Rationale and plan for vitamin d food fortification: a review and guidance paper. Front Endocrinol (Lausanne). 2018;9:373.
   PubMed Web of Science ®Google Scholar
• Chandler PD, Buring JE, Manson JE, Giovannucci EL, Moorthy MV, Zhang S, Lee IM, Lin JH. Circulating vitamin D levels and risk of colorectal cancer in women. Cancer Prev Res (Phila). 2015;8(8):675–82.
   PubMed Web of Science ®Google Scholar
• Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol. 2011;29(28):3775–82.
   PubMed Web of Science ®Google Scholar
• Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther. 2009;30(2):113–25.
   PubMed Web of Science ®Google Scholar
• Estébanez N, Gómez-Acebo I, Palazuelos C, Llorca J, Dierssen-Sotos T. Vitamin D exposure and risk of breast cancer: a meta-analysis. Sci Rep. 2018;8(1):9039.
   PubMed Web of Science ®Google Scholar
• Zhou L, Chen B, Sheng L, Turner A. The effect of vitamin D supplementation on the risk of breast cancer: a trial sequential meta-analysis. Breast Cancer Res Treat. 2020;182(1):1–8.
   PubMed Web of Science ®Google Scholar
• Xu Y, Shao X, Yao Y, Xu L, Chang L, Jiang Z, Lin Z. Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis. J Cancer Res Clin Oncol. 2014;140(9):1465–77.
   PubMed Web of Science ®Google Scholar
• Travis RC, Perez-Cornago A, Appleby PN, Albanes D, Joshu CE, Lutsey PL, Mondul AM, Platz EA, Weinstein SJ, Layne TM, et al. Collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk. Cancer Res. 2019;79(1):274–85.
   PubMed Web of Science ®Google Scholar
• Vaughan-Shaw PG, O’Sullivan F, Farrington SM, Theodoratou E, Campbell H, Dunlop MG, Zgaga L. The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis. Br J Cancer. 2017;116(8):1092–110.
   PubMed Web of Science ®Google Scholar
• Maalmi H, Ordóñez-Mena JM, Schöttker B, Brenner H. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies. Eur J Cancer. 2014;50(8):1510–21.
   PubMed Web of Science ®Google Scholar
• Wang B, Jing Z, Li C, Xu S, Wang Y. Blood 25-hydroxyvitamin D levels and overall mortality in patients with colorectal cancer: a dose-response meta-analysis. Eur J Cancer. 2014;50(12):2173–5.
   PubMed Web of Science ®Google Scholar
• Li M, Chen P, Li J, Chu R, Xie D, Wang H. The impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99(7):2327–36.
   PubMed Web of Science ®Google Scholar
• Yao S, Kwan ML, Ergas IJ, Roh JM, Cheng TD, Hong CC, McCann SE, Tang L, Davis W, Liu S, et al. Association of serum level of vitamin D at diagnosis with breast cancer survival: a case-cohort analysis in the pathways study. JAMA Oncol. 2017;3(3):351–7.
   PubMed Web of Science ®Google Scholar
• Song ZY, Yao Q, Zhuo Z, Ma Z, Chen G. Circulating vitamin d level and mortality in prostate cancer patients: a dose–response meta-analysis. Endocr Connect. 2018;7(12):R294–R303. doi:10.1530/EC-18-0283.
   PubMed Web of Science ®Google Scholar
• Eliassen AH, Warner ET, Rosner B, Collins LC, Beck AH, Quintana LM, Tamimi RM, Hankinson SE. plasma 25-hydroxyvitamin D and risk of breast cancer in women followed over 20 years. Cancer Res. 2016;76(18):5423–30.
   PubMed Web of Science ®Google Scholar
• Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1991–7.
   PubMed Web of Science ®Google Scholar
• Jorde R, Grimnes G. Vitamin D and health: the need for more randomized controlled trials. J Steroid Biochem Mol Biol. 2015;148:269–74.
   PubMed Web of Science ®Google Scholar
• Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O’Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Women’s Health Initiative Investigators, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354(7):684–96.
   PubMed Web of Science ®Google Scholar
• Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, Grant AM, Campbell MK, Anderson FH, Cooper C, RECORD Trial Group, et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). J Clin Endocrinol Metab. 2012;97(2):614–22.
   PubMed Web of Science ®Google Scholar
• Scragg R, Khaw KT, Toop L, Sluyter J, Lawes CMM, Waayer D, Giovannucci E, Camargo CA. Jr. Monthly high-dose vitamin d supplementation and cancer risk: a post hoc analysis of the vitamin D assessment randomized clinical trial. JAMA Oncol. 2018;4(11):e182178.
   PubMed Web of Science ®Google Scholar
• Lappe J, Watson P, Travers-Gustafson D, Recker R, Garland C, Gorham E, Baggerly K, McDonnell SL. Effect of vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial. JAMA. 2017;317(12):1234–43.
   PubMed Web of Science ®Google Scholar
• Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Gordan D, Copeland T, D’Agostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE; VITAL Research Group, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33–44.
   PubMed Web of Science ®Google Scholar
• Keum N, Giovannucci E. Vitamin D supplements and cancer incidence and mortality: a meta-analysis. Br J Cancer. 2014;111(5):976–80.
   PubMed Web of Science ®Google Scholar
• Rejnmark L, Bislev LS, Cashman KD, Eiríksdottir G, Gaksch M, Grübler M, Grimnes G, Gudnason V, Lips P, Pilz S, et al. Non-skeletal health effects of vitamin D supplementation: a systematic review on findings from meta-analyses summarizing trial data. PLoS One. 2017;12(7):e0180512.
   PubMed Web of Science ®Google Scholar
• Chandler PD, Chen WY, Ajala ON, Hazra A, Cook N, Bubes V, Lee IM, Giovannucci EL, Willett W, Buring JE, VITAL Research Group, et al. Effect of vitamin D3 supplements on development of advanced cancer: a secondary analysis of the VITAL Randomized Clinical Trial. JAMA Netw Open. 2020;3(11):e2025850.
   PubMed Web of Science ®Google Scholar
• Keum N, Lee DH, Greenwood DC, Manson JE, Giovannucci E. Vitamin D supplements and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ann Oncol. 2019;30(5):733–43.
   PubMed Web of Science ®Google Scholar
• Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2011;(7):CD007470. doi: 10.1002/14651858.CD007470.pub2.
   PubMed Web of Science ®Google Scholar
• Naska A, Lagiou P. Vitamin D: should public health recommendations also consider cancer outcomes? Ann Oncol. 2019;30(5):667–8.
   PubMed Web of Science ®Google Scholar
• Griffin N, Dowling M. Vitamin D supplementation and clinical outcomes in cancer survivorship. Br J Nurs. 2018;27(19):1121–8.
   PubMedGoogle Scholar
• Zittermann A, Ernst JB, Birschmann I, Dittrich M. Effect of vitamin D or activated vitamin D on circulating 1,25-dihydroxyvitamin D concentrations: a systematic review and metaanalysis of randomized controlled trials. Clin Chem. 2015;61(12):1484–94.
   PubMed Web of Science ®Google Scholar
• Chen F, Du M, Blumberg JB, Ho Chui KK, Ruan M, Rogers G, Shan Z, Zeng L, Zhang FF. Association among dietary supplement use, nutrient intake, and mortality among U.S. adults: a cohort study. Ann Intern Med. 2019;170(9):604–13.
   PubMed Web of Science ®Google Scholar
• Akiba T, Morikawa T, Odaka M, Nakada T, Kamiya N, Yamashita M, Yabe M, Inagaki T, Asano H, Mori S, et al. Vitamin D supplementation and survival of patients with non-small cell lung cancer: a randomized, double-blind, placebo-controlled trial. Clin Cancer Res. 2018;24(17):4089–97.
   PubMed Web of Science ®Google Scholar
• Ng K, Nimeiri HS, McCleary NJ, Abrams TA, Yurgelun MB, Cleary JM, Rubinson DA, Schrag D, Miksad R, Bullock AJ, et al. Effect of High-Dose vs Standard-Dose Vitamin D 3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: The SUNSHINE Randomized Clinical Trial. JAMA. 2019;321(14):1370–9.
   PubMed Web of Science ®Google Scholar
• Urashima M, Ohdaira H, Akutsu T, Okada S, Yoshida M, Kitajima M, Suzuki Y. Effect of vitamin D supplementation on relapse-free survival among patients with digestive tract cancers: The AMATERASU Randomized Clinical Trial. JAMA. 2019;321(14):1361–9.
   PubMed Web of Science ®Google Scholar
• Urashima M, Okuyama M, Akutsu T, Ohdaira H, Kaji M, Suzuki Y. effect of vitamin D supplementation on survival of digestive tract cancer patients with low bioavailable 25-hydroxyvitamin d levels: a post hoc analysis of the AMATERASU randomized clinical trial. Cancers (Basel.). 2020;12(2):347.
   PubMed Web of Science ®Google Scholar
• Bittenbring JT, Neumann F, Altmann B, Achenbach M, Reichrath J, Ziepert M, Geisel J, Regitz E, Held G, Pfreundschuh M. Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab. J Clin Oncol. 2014;32(29):3242–8.
   PubMed Web of Science ®Google Scholar
• Bruns H, Büttner M, Fabri M, Mougiakakos D, Bittenbring JT, Hoffmann MH, Beier F, Pasemann S, Jitschin R, Hofmann AD, et al. Vitamin D-dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphoma. Sci Transl Med. 2015;7(282):282ra47.
   PubMed Web of Science ®Google Scholar
• Hohaus S, Tisi MC, Bellesi S, Maiolo E, Alma E, Tartaglia G, Corrente F, Cuccaro A, D’Alo’ F, Basile U, et al. Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy. Cancer Med. 2018;7(1):270–81.
   PubMed Web of Science ®Google Scholar
• Cunningham TJ, Tabacchi M, Eliane JP, Tuchayi SM, Manivasagam S, Mirzaalian H, Turkoz A, Kopan R, Schaffer A, Saavedra AP, et al. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy. J Clin Invest. 2017;127(1):106–16.
   PubMed Web of Science ®Google Scholar
• Rosenberg AR, Tabacchi M, Ngo KH, Wallendorf M, Rosman IS, Cornelius LA, Demehri S. Skin cancer precursor immunotherapy for squamous cell ­carcinoma prevention. JCI Insight. 2019;4(6):e125476. doi: 10.1172/jci.insight.125476.
   Google Scholar
• Zeichner SB, Koru-Sengul T, Shah N, Liu Q, Markward NJ, Montero AJ, Glück S, Silva O, Ahn ER. Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. Clin Breast Cancer. 2015;15(1):e1–e11.
   PubMedGoogle Scholar
• Madden JM, Murphy L, Zgaga L, Bennett K. De novo vitamin D supplement use post-diagnosis is associated with breast cancer survival. Breast Cancer Res Treat. 2018;172(1):179–90.
   PubMed Web of Science ®Google Scholar
• Duffy MJ, Murray A, Synnott NC, O’Donovan N, Crown J. Vitamin D analogues: potential use in cancer treatment. Crit Rev Oncol Hematol. 2017;112:190–7.
   PubMed Web of Science ®Google Scholar
• Untersmayr E, Kallay E. Insights in immuno-nutrition: vitamin D as a potent immunomodulator. Nutrients. 2020;12(11):3554–5.
   PubMed Web of Science ®Google Scholar
• Song M, Nishihara R, Wang M, Chan AT, Qian ZR, Inamura K, Zhang X, Ng K, Kim SA, Mima K, et al. Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status. Gut. 2016;65(2):296–304.
   PubMed Web of Science ®Google Scholar
• Meeker S, Seamons A, Paik J, Treuting PM, Brabb T, Grady WM, Maggio-Price L. Increased dietary vitamin D suppresses MAPK signaling, colitis, and colon cancer. Cancer Res. 2014;74(16):4398–408.
   PubMed Web of Science ®Google Scholar
• Jiang X, Dimou NL, Al-Dabhani K. Circulating Vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study. Int J Epidemiol. 2019;48(5):1416–1424.
   PubMed Web of Science ®Google Scholar
• Ong JS, Gharahkhani P, An J, Law MH, Whiteman DC, Neale, RE, MacGregor, S.. Vitamin D and overall cancer risk and cancer mortality: a Mendelian randomization study. Hum Mol Genet. 2018;(24):27. doi:10.1093/hmg/ddy307.
   Web of Science ®Google Scholar
• Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, Povoroznyuk V, Balatska N, Barbosa AP, Karonova T, et al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol. 2018;175:125–35.
   PubMed Web of Science ®Google Scholar